FourKites Named to Inc.’s 2021 Best in Business List in the Logistics & Transportation Category
December 08, 2021 07:30 ET
|
FourKites
CHICAGO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- FourKites®, the world’s leading real-time supply chain visibility platform, has been named to the Inc. 2021 Best in Business list in the Logistics and...
For the 2nd Consecutive Year, Liquipel Appears on the Inc. 5000, With Revenue Growth of 207 percent!
September 23, 2021 09:00 ET
|
Liquipel Assurance LLC
IRVINE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Inc. magazine today revealed that Liquipel is on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private...
DISQO Ranks in Top 1000 on the 2020 Inc. 5000
August 18, 2020 11:10 ET
|
Disqo
Consumer insights platform founded on first-party audience records three-year growth of 486 percent. LOS ANGELES, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Consumer insights platform DISQO, known for...
BairesDev selected in Inc. 5000’s List of California’s Fastest-Growing Companies
March 10, 2020 15:00 ET
|
BairesDev
CAMPBELL, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- BairesDev, a software outsourcing company founded in 2009, was recognized on the first edition of California’s Inc. 5000 list, the state-based...
Global Capnography Devices Market was valued at USD 355.0 million in 2018, Observing a CAGR of 4.5% during 2019–2024: VynZ Research
January 09, 2020 13:06 ET
|
VynZ Research
NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The global capnography devices market is expected to grow at a CAGR of 4.5% during the forecast period with its market size valued at USD 355.0 million in...
DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019
September 06, 2019 09:00 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Sept. 06, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that management will attend the Lake Street Capital Markets 3rd Annual Best Ideas Growth...
DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference
September 03, 2019 16:15 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Sept. 03, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that management will present at the 2019 Dougherty & Co. Institutional Investor...
DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
August 13, 2019 16:35 ET
|
DiaMedica Therapeutics Inc.
Phase Ib study of DM199 in Chronic Kidney Disease enrollment completeEncouraging early signals in mechanism biomarkers (NO and PGE2), Kidney function (eGFR) and urine albumin (UACR) Phase II...
DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019
August 12, 2019 08:00 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Aug. 12, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that Rick Pauls, President and CEO, will be presenting at the 2019 Intellisight Conference,...
DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019
August 08, 2019 16:00 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Aug. 08, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its second quarter 2019 financial results will be released after the markets close on...